InterCure Stock

InterCure Equity

The Equity of InterCure (INCR.TA) as of Aug 5, 2026.

Equity

0.00ILS

Last updated:

In 2026, InterCure's equity was 0.00 ILS, a % increase from the 0.00 ILS equity in the previous year.

Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Equity Details

Analyzing InterCure's Equity

InterCure's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding InterCure's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating InterCure's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

InterCure's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in InterCure’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about InterCure stock

On Eulerpool you can find the complete historical development of The Equity InterCure since 2006 – with annual values, charts, and detailed analysis.

The Equity's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's InterCure historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — InterCure

All Key Metrics — InterCure